Jump to main content

博士論文

Transcriptional factor SP1 contributes to defence mechanism against treatment of irinotecan via promoting HB-EGF expression in ovarian clear cell carcinoma.

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

Available in National Diet Library

Find on the publisher's website

国立国会図書館デジタルコレクション

Digital data available

Check on the publisher's website

Transcriptional factor SP1 contributes to defence mechanism against treatment of irinotecan via promoting HB-EGF expression in ovarian clear cell carcinoma.

Persistent ID (NDL)
info:ndljp/pid/9506892
Material type
博士論文
Author
宮田, 康平
Publisher
-
Publication date
2014-03-25
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
福岡大学,博士（医学）
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：

2013

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Transcriptional factor SP1 contributes to defence mechanism against treatment of irinotecan via promoting HB-EGF expression in ovarian clear cell carcinoma.
Author/Editor
宮田, 康平
Author Heading
宮田, 康平
Publication Date
2014-03-25
Publication Date (W3CDTF)
2014-03-25
Alternative Title
転写因子SP1はHB-EGFの発現亢進を介して卵巣明細胞腺癌の塩酸イリノテカン療法に対する防御機構に寄与する。
Degree grantor/type
福岡大学
Date Granted
2014-03-25
Date Granted (W3CDTF)
2014-03-25